Cost-minimisation analysis of erlotinib in the second-line treatment of non-small-cell lung cancer: a Brazilian perspective. (Q46007474)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-minimisation analysis of erlotinib in the second-line treatment of non-small-cell lung cancer: a Brazilian perspective. |
scientific article |
Statements
1 reference
Cost-minimisation analysis of erlotinib in the second-line treatment of non-small-cell lung cancer: a Brazilian perspective. (English)
1 reference
Stephen Doral Stefani
1 reference
Mario Giorgio Saggia
1 reference
Eduardo Augustus Vicino dos Santos
1 reference
1 January 2008
1 reference
11
1 reference
3
1 reference
383-396
1 reference